Hitting HIV's Harpoon

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Abstract

The HIV-1 fusion peptide is a target for broadly neutralizing antibodies. In a recent issue of Nature Medicine, Xu et al. (2018) provide proof-of-concept that vaccination with fusion peptide followed by vaccination with an envelope glycoprotein trimer can induce antibodies in animal models that neutralize diverse HIV-1 viruses. The HIV-1 fusion peptide is a target for broadly neutralizing antibodies. In a recent issue of Nature Medicine, Xu et al. (2018) provide proof-of-concept that vaccination with fusion peptide followed by vaccination with an envelope glycoprotein trimer can induce antibodies in animal models that neutralize diverse HIV-1 viruses.
Original languageEnglish
Pages (from-to)14-15
JournalImmunity
Volume49
Issue number1
DOIs
Publication statusPublished - 2018

Cite this